scholarly journals S2211 Splenic Infarct After a Colonoscopy: Thread Carefully in Heritable Connective Tissue Disorders (HCTD)

2021 ◽  
Vol 116 (1) ◽  
pp. S946-S947
Author(s):  
Smit S. Deliwala ◽  
Brandon T. Wiggins ◽  
Cassandra A. LaMarche ◽  
Rohit Gupta ◽  
Ghassan Bachuwa ◽  
...  
Genes ◽  
2021 ◽  
Vol 12 (6) ◽  
pp. 831
Author(s):  
Jessica Warnink-Kavelaars ◽  
Lisanne de Koning ◽  
Lies Rombaut ◽  
Mattijs Alsem ◽  
Leonie Menke ◽  
...  

Heritable Connective Tissue Disorders (HCTD) show an overlap in the physical features that can evolve in childhood. It is unclear to what extent children with HCTD experience burden of disease. This study aims to quantify fatigue, pain, disability and general health with standardized validated questionnaires. Methods. This observational, multicenter study included 107 children, aged 4–18 years, with Marfan syndrome (MFS), 58%; Loeys-Dietz syndrome (LDS), 7%; Ehlers-Danlos syndromes (EDS), 8%; and hypermobile Ehlers-Danlos syndrome (hEDS), 27%. The assessments included PROMIS Fatigue Parent–Proxy and Pediatric self-report, pain and general health Visual-Analogue-Scales (VAS) and a Childhood Health Assessment Questionnaire (CHAQ). Results. Compared to normative data, the total HCTD-group showed significantly higher parent-rated fatigue T-scores (M = 53 (SD = 12), p = 0.004, d = 0.3), pain VAS scores (M = 2.8 (SD = 3.1), p < 0.001, d = 1.27), general health VAS scores (M = 2.5 (SD = 1.8), p < 0.001, d = 2.04) and CHAQ disability index scores (M = 0.9 (SD = 0.7), p < 0.001, d = 1.23). HCTD-subgroups showed similar results. The most adverse sequels were reported in children with hEDS, whereas the least were reported in those with MFS. Disability showed significant relationships with fatigue (p < 0.001, rs = 0.68), pain (p < 0.001, rs = 0.64) and general health (p < 0.001, rs = 0.59). Conclusions. Compared to normative data, children and adolescents with HCTD reported increased fatigue, pain, disability and decreased general health, with most differences translating into very large-sized effects. This new knowledge calls for systematic monitoring with standardized validated questionnaires, physical assessments and tailored interventions in clinical care.


2018 ◽  
Vol 118 (7) ◽  
pp. 1301-1307 ◽  
Author(s):  
Jacob K. Jensen ◽  
Rie H. Nygaard ◽  
Rene B. Svensson ◽  
Hanne D. Hove ◽  
S. Peter Magnusson ◽  
...  

2019 ◽  
Vol 114 (8) ◽  
pp. 1343-1345 ◽  
Author(s):  
Saikiran M. Kilaru ◽  
Kenneth J. Mukamal ◽  
Judy W. Nee ◽  
Sveta S. Oza ◽  
Anthony J. Lembo ◽  
...  

2014 ◽  
Vol 33 ◽  
pp. 35-40 ◽  
Author(s):  
Amr Salam ◽  
Michael A. Simpson ◽  
Kristina L. Stone ◽  
Takuya Takeichi ◽  
Arti Nanda ◽  
...  

Neurology ◽  
1998 ◽  
Vol 50 (4) ◽  
pp. 1166-1169 ◽  
Author(s):  
W. I. Schievink ◽  
E.F.M. Wijdicks ◽  
V. V. Michels ◽  
J. Vockley ◽  
M. Godfrey

2016 ◽  
Vol 22 (6) ◽  
pp. 624-637 ◽  
Author(s):  
Sarasa T Kim ◽  
Waleed Brinjikji ◽  
Giuseppe Lanzino ◽  
David F Kallmes

Patients with connective tissue diseases are thought to be at a higher risk for a number of cerebrovascular diseases such as intracranial aneurysms, dissections, and acute ischemic strokes. In this report, we aim to understand the prevalence and occurrences of such neurovascular manifestations in four heritable connective tissue disorders: Marfan syndrome, Ehlers-Danlos syndrome, Neurofibromatosis Type 1, and Loeys-Dietz syndrome. We discuss the fact that although there are various case studies reporting neurovascular findings in these connective tissue diseases, there is a general lack of case-control and prospective studies investigating the true prevalence of these findings in these patient populations. Furthermore, the differences observed in the manifestations and histology of such disease pathologies encourages future multi-center registries and studies in better characterizing the pathophysiology, prevalence, and ideal treatment options of neurovascular lesions in patents with connective tissue diseases.


Sign in / Sign up

Export Citation Format

Share Document